1.69 Revance Therapeutics, Inc. (NASDAQ:RVNC) is favoured by institutional owners who hold 63% of the company

News


<< back

Revance Therapeutics, Inc. (NASDAQ:RVNC) is favoured by institutional owners who hold 63% of the company
Date: 2024-04-12 [news.yahoo.com]

READ THE FULL NEWS >>
×